Calimac-LB Injection
Calcium Gluconate 50 mg + Calcium Lactobionate 87.5 mg Injection — IV Calcium Replacement
| Composition | Calcium Gluconate 50 mg + Calcium Lactobionate 87.5 mg per ml |
|---|---|
| Dosage Form | Injection (IV/IM) |
| Pack Type | Ampoule / Vial |
| Pack Size | 10 ml Ampoule |
| MRP | ₹ 1790 |
| Therapy | Injectable + Orthopaedics — Parenteral Calcium Replacement |
| Storage | Store below 25 °C in a dry place, protected from light. Do not freeze. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Calimac-LB Injection
Calimac-LB Injection contains Calcium Gluconate 50 mg + Calcium Lactobionate 87.5 mg per ml for parenteral calcium replacement. It is indicated for acute symptomatic hypocalcaemia (carpopedal spasm, tetany, laryngospasm, cardiac arrhythmias), hypocalcaemic seizures and as adjunctive therapy in conditions requiring rapid calcium correction.
Calcium Gluconate is generally preferred over Calcium Chloride for IV administration due to less tissue irritation if extravasation occurs. The addition of Calcium Lactobionate provides additional elemental calcium with good tissue tolerance. The combination is widely used in obstetric (eclampsia), surgical (post-thyroidectomy hypocalcaemia) and emergency settings.
Calimac-LB is manufactured by Trumac Healthcare under WHO-GMP injectable conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a high-volume hospital/critical-care SKU.
Indications
- Acute symptomatic hypocalcaemia (tetany, carpopedal spasm)
- Hypocalcaemic seizures
- Post-thyroidectomy / parathyroidectomy hypocalcaemia
- Hypocalcaemic cardiac arrhythmias
- Calcium channel blocker or magnesium overdose (antidote)
- Hypermagnesaemia management
- Eclampsia adjunctive therapy
Mechanism of Action
IV calcium directly raises ionised serum calcium concentration, reversing the neuromuscular hyperexcitability of hypocalcaemia and stabilising cardiac membranes. Calcium acts as a competitive antagonist at sites where magnesium or other agents are causing toxicity.
Dosage & Administration
Adults: 10–20 ml by slow IV infusion (no faster than 1.5 ml/min). Strictly hospital use by trained medical professionals. Avoid IM in children (tissue necrosis risk). ECG monitoring during administration.
Side Effects
Pain at injection site, hypotension if infused too rapidly, bradycardia, arrhythmias. Tissue necrosis if extravasation. Calcinosis with rapid IV in renal impairment.
Contraindications & Precautions
Hypercalcaemia. Ventricular fibrillation. Digitalis toxicity (calcium worsens). Severe renal impairment (caution). Calcium-containing renal stones.
Storage
Store below 25 °C in a dry place, protected from light. Do not freeze.
Calimac-LB Injection is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Calimac-LB Injection used for?
Calimac-LB is parenteral calcium for acute hypocalcaemia, hypocalcaemic seizures, post-thyroidectomy hypocalcaemia, calcium channel blocker overdose and hypermagnesaemia.
How is Calimac-LB given?
By slow IV infusion (no faster than 1.5 ml/min) under medical supervision. Strictly hospital use with ECG monitoring.
Is Calimac-LB available for PCD pharma franchise?
Yes, on monopoly-based PCD pharma franchise, government tenders and third-party manufacturing.
How should Calimac-LB be stored?
Store below 25 °C in a dry place, protected from light. Do not freeze.
Is Calimac-LB WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant injectable facilities.
Related Products
- Calimac Tablet — Calcium Carbonate 1250 mg (Equivalent to Elemental Calcium 500 mg)
- Calcirut Tablet — Calcium Citrate 1000 mg + Calcitriol 0.25 mcg + Magnesium
- Calcirut Soft Gel Capsule — Calcitriol 0.25 mcg + Calcium Citrate 500 mg + Zinc Oxide